<qa>  What is the purpose of the Expanded Access Program?The purpose of the Expanded Access Program is to provide oral Domperidone to patients 12 years of age where, according to the investigators judgment, a prokinetic effect is needed for the relief of refractory gastroesophageal reflux disease with upper gastrointestinal GI symptoms, gastroparesis, and chronic constipation. 